Weight loss drugs are reaching an inflection point with the introduction of oral obesity pills. Join Patrick Coffey and Emily Field as they review the forces driving explosive growth for GLP-1s, exploring what really matters as the market shifts from specialist care to consumer adoption. Typically, when interest rates rise, there is a corresponding decline in […]
